Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' rada...
JP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management's outlook for recovery and g...
A federal court blocked NIH's policy capping indirect cost rates on research grants, ruling it unlawful. The decision safeg...
It's a good time to look at how the major U.S. stock industry ETFs performed this month, as April comes to an end. In April...
The passing of Ruth Bader Ginsburg is creating a stir for some health care stocks, prompting the investment community to ponder...
